A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center.
A new, non-invasive tinnitus treatment is available at Thomas Jefferson University Hospital.
Transplantation expert to be director of live donor liver transplant program.
Thomas Jefferson University Hospital is the only hospital in the Delaware Valley offering endoluminal fundoplication.
Directly inhibiting the activity of a key protein mediator of inflammation reduced radiation toxicity in zebrafish embryos, and may ultimately be of help to patients receiving radiation therapy, according to researchers from the Kimmel Cancer Center at Jefferson.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
Only program in the Philadelphia Region – and second in the country – to offer unique, targeted chemotherapy delivery technique for Retinoblastoma
A new study conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania shows an investigational, orally-inhaled therapy is effective in treating migraines. The multi-center, phase three FREEDOM-301 trial for the orally-inhaled migraine therapy, LEVADEX, shows study participants had significant relief from symptoms such as pain, nausea and light and sound sensitivity when compared to placebo treatment.
Cataldo Doria, M.D., Ph.D., F.A.C.S., director, Division of Transplant Surgery, in the Department of Surgery at Thomas Jefferson University Hospital, has been named the Nicoletti Family Professor of Transplant Surgery. This endowed professorship is a generous gift of Robert and Beatrice Nicoletti and their family. The family cited the care they received at Jefferson when Robert received a new kidney donated by his own daughter, as the reason for their donation.
Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson. Their study was published in the August edition of the journal Surgery.
Thomas Jefferson University Hospital (TJUH) is proud to announce funding from Verizon Foundation which helps to expand programs that address the heart of social issues such as literacy, technology, education and domestic violence. Jefferson's Department of Emergency Medicine received a $24,500 grant for its Domestic Violence Prevention Program; and the Department of Family Medicine's pediatric practice and the Jefferson-duPont Children's Health Program, received a $10,000 grant for Reach Out and Read, a program dedicated to instilling the love of books and reading in underserved preschool children in Philadelphia.
Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer.
The American Cancer Society today launched its Patient Navigator Program at the Kimmel Cancer Center at Jefferson in Philadelphia, thanks to support received from AstraZeneca Pharmaceuticals LP . This is the first site to launch in Pennsylvania as part of a strategic nationwide effort to significantly extend the reach of this innovative program and assist individual cancer patients in negotiating the health care system.
Leonard P. Freedman, Ph.D., recently joined Jefferson Medical College of Thomas Jefferson University in the newly created position of Vice Dean for Research. In this role, Dr. Freedman is responsible for advancing the medical college's research mission by developing a clear, coordinated strategy that drives the effective integration of the clinical/educational expertise on campus with Jefferson's basic and clinical research faculty.
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. The study, available in the current edition of the Journal of Clinical Neuromuscular Disease, may help doctors more effectively diagnose and treat CIDP.
Scientists at Jefferson Medical College have received a five-year, $1.7 million National Institutes of Health grant funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to study mechanisms regulating stem cell self-renewal and differentiation with the aim of regenerating diseased and painful intervertebral discs.
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.
A pain condition common in people with migraines also has a high prevalence in patients with cluster headache, according to a study conducted by researchers at the Jefferson Headache Center at Jefferson Hospital for Neuroscience.
Judith Rodin, Ph.D., president of The Rockefeller Foundation and former president of the University of Pennsylvania, will address the graduating classes at the 185th annual commencement exercises for Jefferson Medical College and Jefferson College of Graduate Studies. She will receive an honorary doctor of science degree during the Friday, May 29th ceremonies at 10:30 a.m., at the Kimmel Center for the Performing Arts on South Broad Street in Philadelphia.
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
After surgery to remove the head of the pancreas, invagination of the pancreas into the small intestine resulted in a lower rate of pancreatic fistula, according to researchers at the Jefferson Pancreas, Biliary and Related Cancer Center. The research was published in the Journal of the American College of Surgeons. It was performed as a randomized trial "“ the gold standard for studies.
A combination of sorafenib and vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Center at Jefferson. Data from the two studies were presented at the AACR 100th Annual Meeting 2009 in Denver.
Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009.
An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver.
A protein called Mcl-1 plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis, according to research published this week in Molecular Cancer Research.
Piera Pasinelli, Ph.D., co-director of the Frances and Joseph Weinberg Unit for ALS Research at the Farber Institute for Neurosciences at Thomas Jefferson University was recently awarded a Margaret Q. Landenberger Research Foundation grant to identify why drug therapies that showed promise in Amyotrophic Lateral Sclerosis (ALS) mouse models have proven unsuccessful in human clinical trials.
The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported in the Journal of Clinical Investigation.
A clinical study of cardiac patients who suffered an allergic reaction to the widely-prescribed drug clopidogrel, also known by the pharmaceutical name Plavix, found that treatment with a combination of steroids and antihistamines can alleviate the allergic reaction symptoms thereby allowing patients to remain on the drug.
An important clinical repercussion in the treatment of epilepsy has been discovered by a research team led by Scott Mintzer, M.D., assistant professor in the Department of Neurology and the Jefferson Comprehensive Epilepsy Center at Jefferson Medical College of Thomas Jefferson University. The team has determined that two of the most commonly prescribed anti-seizure medications may lead to significantly increased levels of cholesterol, C-reactive protein and other markers of cardiovascular disease risk.
A novel signaling pathway plays a significant role in the production of aldosterone, a hormone that promotes heart failure after a myocardial infarction, according to a study conducted by Thomas Jefferson University researchers.
Researchers from Thomas Jefferson University have identified a protein that appears to play a significant role in the growth and migration of prostate cancer cells, especially androgen-independent prostate cancer cells.
Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.
Michael J. Vergare, M.D., the Daniel Lieberman Professor and Chair of the Department of Psychiatry and Human Behavior at Jefferson Medical College of Thomas Jefferson University, has been appointed Senior Vice President for Academic Affairs. In this role, Dr. Vergare will serve as the central focal point for the academic, administrative and support functions of the university. The appointment is effective immediately.
Jefferson researchers reported in Nature the discovery of a key protein regulator of inflammation and cell death.
With a pre-emptive, prophylactic skin regimen, patients who receive panitumumab for treatment of metastatic colorectal cancer may be able to avoid some of the skin-associated toxicities, according to data presented at the 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco.
African-American patients with colorectal were more likely to present with worse pathological features at diagnosis and to have a worse five-year survival rate compared to Caucasian patients, according to a study conducted by researchers at Thomas Jefferson University.
Abdolmohamad Rostami, M.D. Ph. D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and director of the Multiple Sclerosis and Neuroimmunology Research Laboratory at Jefferson Hospital for Neuroscience has been elected the 126th President of the Philadelphia Neurological Society.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
The Department of Health and Human Services recently awarded Jefferson Hospital for Neuroscience (JHN) the Medal of Honor for achieving a lifesaving organ donation conversion rate of 75 percent or greater for a sustained 12-month period. The award was given during the fourth National Learning Congress held in Nashville, Tennessee in October.
Researchers at Thomas Jefferson University have found that a lower dose of fractionated stereotactic radiotherapy for acoustic neuromas results in better hearing preservation and has the same tumor local control rate as a higher dose of therapy. The study appeared online in the International Journal of Radiation Oncology*Biology*Physics.
Scott Mintzer, M.D., assistant professor in the Department of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Epilepsy Monitoring Unit at the Jefferson Comprehensive Epilepsy Center of Jefferson Hospital for Neuroscience was recently awarded a Junior Investigator grant from the National Institutes of Health (NIH) to study the adverse metabolic effects of antiepileptic seizure medications.
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association.
Jefferson researchers Kevin Takakuwa, M.D. and Ethan Halpern, M.D., received the 2008 Philips CT NetForum Publication of the Year award. The award is given by Philips Medical Systems, who announced the winner at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America.
The Kimmel Cancer Center at Jefferson has been designated a Center of Excellence by the Fertile Hope organization. The organization recognizes cancer centers that actively address reproductive needs of their patients and survivors by designating them as Centers of Excellence.
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience.
Leonard Gomella, M.D., was appointed Clinical Director of the Jefferson Kimmel Cancer Center Network. Three new Associate Clinical Directors were also appointed to the leadership team.
After an extensive national search, Mark L. Tykocinski, M.D., has been named dean of Jefferson Medical College and senior vice president of Thomas Jefferson University in Philadelphia. Dr. Tykocinski will also serve as president of Jefferson University Physicians, the faculty practice plan. The University Board of Trustees' appointment takes effect December 1, 2008.
Stephen C. Peiper, M.D., appointed Chairman of Pathology, Anatomy and Cell Biology at Jefferson.
Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right